Opportunity Information: Apply for RFA HG 19 004
The Human Genome Reference Center (HGRC) funding opportunity (RFA-HG-19-004) is a National Institutes of Health (NIH), National Human Genome Research Institute (NHGRI) cooperative agreement (U41) aimed at creating and supporting a central, coordinating hub for the Human Genome Reference Program (HGRP). The basic purpose is to ensure the human genome reference is continuously maintained, improved, and delivered to the broader scientific community as a trusted, high-quality resource. This opportunity is explicitly marked "Clinical Trial Not Allowed," meaning the work is intended to be resource development, coordination, standards, and reference genome improvement rather than interventional clinical research.
At the core of the award is the expectation that the HGRC will function as the main operational and strategic center of a larger multi-component program. Practically, that means the HGRC is expected to lead the ongoing stewardship of the human reference genome and manage the process of updating it as new data, methods, and community needs emerge. A major focus is on incorporating new, high-quality genome assemblies into the reference in a way that is systematic and standards-driven. The center is also expected to help drive decisions about which samples should be prioritized for new assemblies, working in close coordination with other program components and with input from the broader genomics community. This reflects a shift from treating the reference as a mostly static product to treating it as an actively curated, evolving infrastructure.
Another central feature of the HGRC mission is improving the way the reference represents human diversity, especially through state-of-the-art representations of alternate haplotypes. In modern genomics, a single linear reference sequence is often not enough to represent real human genetic variation, so the program emphasizes improved representation of alternative genomic sequences and haplotypes, including those created by other HGRP components. In addition to the technical work of integration and representation, the HGRC is expected to identify and respond to different user needs across the community. That includes both basic research users and clinically oriented users who rely on accurate reference representations for variant interpretation, benchmarking, and downstream analysis.
Because the human genome reference is part of a global ecosystem of data and tools, the HGRC is also expected to liaise with, coordinate with, or otherwise align efforts across other national and international resources that represent human genomic sequence and variation. This includes coordinating with groups that provide reference resources for humans and other organisms where there are shared standards, interoperability issues, or common technical challenges. The funding announcement notes that this and related opportunities are intended to replace and update NHGRI's current contributions to the Genome Reference Consortium (GRC), signaling an evolution in how NHGRI organizes and supports the reference genome enterprise.
The award mechanism is a cooperative agreement (U41), which typically means NIH expects substantial scientific and programmatic involvement during the period of performance. In other words, this is not simply a hands-off grant; it is designed as a partnership where NHGRI and the awardee coordinate closely on milestones, priorities, deliverables, and integration with the rest of the HGRP. The activity category is Health and the CFDA number listed is 93.172.
Eligibility is broad across U.S.-based organizations and includes many types of public and private entities. Eligible applicants include state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; certain tribal organizations; public housing authorities/Indian housing authorities; nonprofits (both 501(c)(3) and non-501(c)(3)); for-profit organizations (other than small businesses); small businesses; and other eligible entities. The announcement also highlights categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), as well as faith-based or community-based organizations and U.S. territories or possessions.
Foreign eligibility is constrained in a specific way. Non-domestic (non-U.S.) entities (foreign organizations and foreign institutions) are not eligible to apply as the applicant organization, and non-domestic components of U.S. organizations are not eligible to apply. However, foreign components as defined in the NIH Grants Policy Statement are allowed, meaning a U.S. applicant can include certain foreign collaborators or parts of the project performed abroad when permitted under NIH policy and justified scientifically.
Key administrative details included in the source information are that the opportunity was created on January 30, 2019, and the original closing date was April 2, 2019. The funding instrument type is listed as a cooperative agreement, and while an award ceiling and expected number of awards are not provided in the excerpt, the overall structure indicates NHGRI was seeking a single central resource or a very small number of tightly coordinated awards to serve as the program hub.Apply for RFA HG 19 004
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Human Genome Reference Center (HGRC) (U41 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.172.
- This funding opportunity was created on 2019-01-30.
- Applicants must submit their applications by 2019-04-02. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: Neural Regulation of Cancer (R01 Clinical Trial Not Allowed)
Previous opportunity: Summer Seminars and Institutes for K-12 Educators
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA HG 19 004
Applicants also applied for:
Applicants who have applied for this opportunity (RFA HG 19 004) also looked into and applied for these:
| Funding Opportunity |
|---|
| Research and Development for Genome Reference Representations (GRR) (U01 Clinical Trial Not Allowed) Apply for RFA HG 19 003 Funding Number: RFA HG 19 003 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: Mutant Mouse Resource and Research Centers (U42 Clinical Trial Not Allowed) Apply for PAR 19 175 Funding Number: PAR 19 175 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed) Apply for PAR 19 177 Funding Number: PAR 19 177 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Patient Safety Learning Laboratories (2019): Pursuing Safety in Diagnosis and Treatment at the Intersection of Design, Systems Engineering, and Health Services Research (R18) Apply for RFA HS 19 001 Funding Number: RFA HS 19 001 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Secondary Data Analysis to Examine Long-Term and/or Potential Cross-Over Effects of Prevention Interventions: What are the Benefits for Preventing Mental Health Disorders? (R01 Clinical Trial Not Allowed) Apply for RFA MH 20 110 Funding Number: RFA MH 20 110 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Centers for Medical Countermeasures Against Radiation Consortium (U19 Clinical Trial Not Allowed) Apply for RFA AI 19 012 Funding Number: RFA AI 19 012 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Initiative to Maximize Research Education in Genomics: Courses (R25 Clinical Trial Not Allowed) Apply for PAR 19 185 Funding Number: PAR 19 185 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Notice of Stakeholders Meeting on USAID/PEPFAR Strategic Plan for Strengthening Indigenous Partnerships Apply for 720611 LOCAL PARTNER STRATEGY MEETING Funding Number: 720611 LOCAL PARTNER STRATEGY MEETING Agency: Zambia USAID-Lusaka Category: Health Funding Amount: Case Dependent |
| Tuberculosis Implementation Framework Agreement (TIFA) Apply for 7200AA19RFA00008 Funding Number: 7200AA19RFA00008 Agency: Agency for International Development Category: Health Funding Amount: $300,000,000 |
| Tobacco Regulatory Science (R01 Clinical Trial Optional) Apply for RFA OD 19 019 Funding Number: RFA OD 19 019 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Pilot Services Research Grants Not Involving Clinical Trials (R34 Clinical Trial Not Allowed) Apply for PAR 19 189 Funding Number: PAR 19 189 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Understanding the Mechanisms of Neuropsychiatric Side Effects and Neurological Toxicities of HIV Medicines (R21 Clinical Trial Not Allowed) Apply for RFA MH 20 115 Funding Number: RFA MH 20 115 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Centers of Excellence in Genomic Science (RM1 Clinical Trials Optional) Apply for PAR 19 204 Funding Number: PAR 19 204 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: NEI - DOD Vision Research Collaborative (R01 Clinical Trial Not Allowed) Apply for PAR 19 203 Funding Number: PAR 19 203 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: NIGMS Legacy Community-Wide Scientific Resources (R24 Clinical Trial Not Allowed) Apply for PAR 19 208 Funding Number: PAR 19 208 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional) Apply for PAR 19 209 Funding Number: PAR 19 209 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Geroscience Approaches to Alzheimer's Disease (R01 Clinical Trial Not Allowed) Apply for RFA AG 20 013 Funding Number: RFA AG 20 013 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Emerging Infectious Diseases Research Centers (U01 Clinical Trial Not Allowed) Apply for RFA AI 19 028 Funding Number: RFA AI 19 028 Agency: National Institutes of Health Category: Health Funding Amount: $850,000 |
| NINDS Institutional Research Training Program (T32) Apply for PAR 19 211 Funding Number: PAR 19 211 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Progression Markers for Cognitive Impairment in Parkinson's Disease Dementia (R01 Clinical Trial Not Allowed) Apply for PAS 19 210 Funding Number: PAS 19 210 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA HG 19 004", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
